Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
150 participants
OBSERVATIONAL
2019-10-10
2020-05-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Use of Statin in Diabetic Patients Not Known to Have Atherosclerotic Cardiovascular Disease
NCT06676683
Vitamin C Supplementation Plus Hypoglycemic Agents Versus Hypoglycemic Agents Alone in Type 2 Diabetes Mellitus
NCT01319734
The Effects of DPPIs on Cognitive Function of Diabetic Patients
NCT06164535
Effect of Medicago Sativa on Oral Glucose Tolerance in Healthy Adults
NCT03714438
Effect of Coccinia Cordifolia Extract on Blood Sugar of Newly Diagnosed Diabetics
NCT00502008
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aim of this study was to evaluate colchicine effect on A1C of newly diagnosed type2 diabetes compared to the metformin and control group on diet only.
The first group patients received colchicine 0.5twice daily for 6 months, the second group received metformin 1gm twice daily, the third group patients were on diet only. During the period of treatment, the investigators followed the patients if there were side effects of the drugs used. No side effects were monitored during the period of treatment except for gastric upset in some patients using metformin
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
group 1 on cochicine
The first group patients received colchicine 0.5 twice daily for 6 months
Colchicine Tablets
colchicine tabletes for 6 months
group 2 on glucophage 1 gm twice daily
second group received glucophage 1gm twice daily for 6 months
Colchicine Tablets
colchicine tabletes for 6 months
group 3 control
the third group patients were on diet only for 6 months
Colchicine Tablets
colchicine tabletes for 6 months
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Colchicine Tablets
colchicine tabletes for 6 months
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
35 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ministry of Health and Population, Egypt
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
mahmoud younis
consultant
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mahmoud Younis
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.